ASAM Pocket Guidelines and Patient Guide

Benzodiazepine Tapering

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1532950

Contents of this Issue

Navigation

Page 12 of 29

13 Table 4. Benzodiazepine Tapering Considerations by Pregnancy Trimester 1st trimester 2nd trimester 3rd trimester Postpartum Potential Fetal Effects of BZDs Minimal evidence of fetal malformations Increased risk of preterm birth Increased risk of preterm birth, low birth weight, cesarean delivery, ventilatory support Concern for withdrawal and potential fetal effects if high doses are used during lactation Potential Effects of Pregnancy on BZD Pharmacokinetics Increased volume of distribution and CYP2C19, CYP3A4, and CYP2C9 metabolism (resulting in decreased effect) Decreased CYP1A2 and CYP2C19 activity Increased volume of distribution and CYP2C19, CYP3A4, and CYP2C9 metabolism (resulting in decreased effect) Decreased CYP1A2 and CYP2C19 activity Increased volume of distribution and CYP2C19, CYP3A4, and CYP2C9 metabolism (resulting in decreased effect) Decreased CYP1A2 and CYP2C19 activity Reversal of pregnancy changes may increase effect Causes of Insomnia Nausea, urinary frequency, back pain Fetal movements, heartburn, leg cramps, shortness of breath Fetal movements, heartburn, leg cramps, shortness of breath Infant care, pain

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Benzodiazepine Tapering